Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6407 ARTÍCULOS , VIENDO DEL 3946 AL 3960

Dopamine transporter scanning in the evaluation of patients with suspected Parkinsonism: a case-based user's guide

Rodriguez-Porcel F, Jamali S, Duker AP, Espay AJ.

Expert Rev Neurother. 2016;16(1):23-9. doi: 10.1586/14737175.2015.1120160. Epub 2015 Dec 2.

Novel GNAL mutation with intra-familial clinical heterogeneity: Expanding the phenotype

Carecchio M, Panteghini C, Reale C, Barzaghi C, Monti V, Romito L, Sasanelli F, Garavaglia B.

Parkinsonism Relat Disord. 2016 Feb;23:66-71. doi: 10.1016/j.parkreldis.2015.12.012. Epub 2015 Dec 18.

Deep brain stimulation: current applications and future prospects

Suchorska B, Ruge MI.

Discov Med. 2015 Dec;20(112):403-11.

The Effectiveness of Transcranial Brain Stimulation in Improving Clinical Signs of Hyperkinetic Movement Disorders

Obeso I, Cerasa A, Quattrone A.

Front Neurosci. 2016 Jan 7;9:486. doi: 10.3389/fnins.2015.00486. eCollection 2015.

Isolated and combined dystonia syndromes - an update on new genes and their phenotypes

Balint B, Bhatia KP.

Eur J Neurol. 2015 Apr;22(4):610-7. doi: 10.1111/ene.12650. Epub 2015 Jan 29.

Uncommon applications of deep brain stimulation in hyperkinetic movement disorders

Smith KM, Spindler MA.

Tremor Other Hyperkinet Mov (N Y). 2015 Feb 2;5:278. doi: 10.7916/D84X56HP. eCollection 2015.

Late Emergence of Parkinsonian Phenotype and Abnormal Dopamine Transporter Scan in Chorea-Acanthocytosis

Nagy A, Noyce A, Velayos-Baeza A, Lees AJ, Warner TT, Ling H.

Mov Disord Clin Pract. 2015 Mar 16;2(2):182-186. doi: 10.1002/mdc3.12138. eCollection 2015 Jun.

Cognitive Behavioral Therapy in Movement Disorders: A Review

Berardelli I, Pasquini M, Roselli V, Biondi M, Berardelli A, Fabbrini G.

Mov Disord Clin Pract. 2015 Jun 2;2(2):107-115. doi: 10.1002/mdc3.12160. eCollection 2015 Jun.

Deep brain stimulation for movement disorders: update on recent discoveries and outlook on future developments

Mahlknecht P, Limousin P, Foltynie T.

J Neurol. 2015 Nov;262(11):2583-95. doi: 10.1007/s00415-015-7790-8. Epub 2015 Jun 3.

Extrapyramidal system neurotoxicity: animal models

Dorman D.

Handb Clin Neurol. 2015;131:207-23. doi: 10.1016/B978-0-444-62627-1.00012-3.

Unusual cerebral white matter change in a Chinese family with Spinocerebellar ataxia type 12

Hu T, Zhao B, Wei QQ, Shang H.

J Neurol Sci. 2015 Feb 15;349(1-2):243-5. doi: 10.1016/j.jns.2014.12.045. Epub 2015 Jan 5.

The first Japanese familial case of spinocerebellar ataxia 23 with a novel mutation in the PDYN gene

Saigoh K, Mitsui J, Hirano M, Shioyama M, Samukawa M, Ichikawa Y, Goto J, Tsuji S, Kusunoki S.

Parkinsonism Relat Disord. 2015 Mar;21(3):332-4. doi: 10.1016/j.parkreldis.2014.12.028. Epub 2015 Jan 3.

Fragile X-associated tremor/ataxia syndrome

Hagerman PJ, Hagerman RJ.

Ann N Y Acad Sci. 2015 Mar;1338(1):58-70. doi: 10.1111/nyas.12693. Epub 2015 Jan 26.

The therapeutic potential of cannabinoids for movement disorders

Kluger B, Triolo P, Jones W, Jankovic J.

Mov Disord. 2015 Mar;30(3):313-27. doi: 10.1002/mds.26142. Epub 2015 Feb 4.

[A case of Isaacs' syndrome causing various central nervous symptoms successfully treated with high-dose intravenous methylprednisolone therapy]

Shimmura M, Maeda N, Kanetou S, Takashima N, Takase K.

Rinsho Shinkeigaku. 2015;55(1):37-40. doi: 10.5692/clinicalneurol.55.37.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias